APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coccidiosis Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Coccidiosis Vaccines Industry Growth and Trends Forecast to 2032

28 December 2025100 pages

Choose your research edition.

Industry ResearchCoccidiosis Vaccines Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Coccidiosis Vaccines Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Coccidiosis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coccidiosis Vaccines Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Coccidiosis Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Coccidiosis Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Coccidiosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Coccidiosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coccidiosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coccidiosis Vaccines include Biopharm, Bioproperties, Boehringer Ingelheim, Ceva Santé Animale, HIPRA, Huvepharma, MSD Animal Health, Nisseiken and Vaxxinova, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Coccidiosis Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Coccidiosis Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Coccidiosis Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Coccidiosis Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Coccidiosis Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Coccidiosis Vaccines Market by Company

Biopharm

Bioproperties

Boehringer Ingelheim

Ceva Santé Animale

HIPRA

Huvepharma

MSD Animal Health

Nisseiken

Vaxxinova

Foshan Standard Biotech

Guangdong Winsun Bio-pharmaceutical

Hlinte

Qilu Qingda Bio-Pharmaceutical

Skystar Bio-pharm

Coccidiosis Vaccines Segment by Type

Attenuated Vaccines

Non-attenuated Vaccines

Coccidiosis Vaccines Segment by Application

Poultry

Rabbit

Others

Coccidiosis Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coccidiosis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coccidiosis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coccidiosis Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coccidiosis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Coccidiosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Attenuated Vaccines Table 2. Major Company of Non-attenuated Vaccines Table 3. Global Coccidiosis Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units) Table 5. Global Coccidiosis Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Coccidiosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Coccidiosis Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Coccidiosis Vaccines Price by Type (2021-2026) & (US$/Unit) Table 9. Global Coccidiosis Vaccines Sales by Type (2027-2032) & (K Units) Table 10. Global Coccidiosis Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Coccidiosis Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Coccidiosis Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Coccidiosis Vaccines Price by Type (2027-2032) & (US$/Unit) Table 14. North America Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units) Table 15. North America Coccidiosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units) Table 17. Europe Coccidiosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Coccidiosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units) Table 21. Latin America Coccidiosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Coccidiosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Coccidiosis Vaccines Industry Trends Table 25. Coccidiosis Vaccines Industry Drivers Table 26. Coccidiosis Vaccines Industry Opportunities and Challenges Table 27. Coccidiosis Vaccines Industry Restraints Table 28. Global Coccidiosis Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Coccidiosis Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Coccidiosis Vaccines Sales by Company (2021-2026) & (K Units) Table 31. Global Coccidiosis Vaccines Sales Share by Company (2021-2026) Table 32. Global Coccidiosis Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Coccidiosis Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Coccidiosis Vaccines Major Company Production Sites and Headquarters Table 35. Global Coccidiosis Vaccines Company, Product Type & Application Table 36. Global Coccidiosis Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Coccidiosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Coccidiosis Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Coccidiosis Vaccines Sales by Region (2021-2026) & (K Units) Table 41. Global Coccidiosis Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Coccidiosis Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Coccidiosis Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Coccidiosis Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Coccidiosis Vaccines Sales by Region (2027-2032) & (K Units) Table 46. Global Coccidiosis Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Coccidiosis Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Coccidiosis Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Coccidiosis Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Coccidiosis Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units) Table 52. Global Coccidiosis Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Coccidiosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Coccidiosis Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Coccidiosis Vaccines Price by Application (2021-2026) & (US$/Unit) Table 56. Global Coccidiosis Vaccines Sales by Application (2027-2032) & (K Units) Table 57. Global Coccidiosis Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Coccidiosis Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Coccidiosis Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Coccidiosis Vaccines Price by Application (2027-2032) & (US$/Unit) Table 61. North America Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units) Table 62. North America Coccidiosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units) Table 64. Europe Coccidiosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Coccidiosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units) Table 68. Latin America Coccidiosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Coccidiosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Biopharm Company Information Table 72. Biopharm Business Overview Table 73. Biopharm Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Biopharm Coccidiosis Vaccines Product Portfolio Table 75. Biopharm Recent Development Table 76. Bioproperties Company Information Table 77. Bioproperties Business Overview Table 78. Bioproperties Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bioproperties Coccidiosis Vaccines Product Portfolio Table 80. Bioproperties Recent Development Table 81. Boehringer Ingelheim Company Information Table 82. Boehringer Ingelheim Business Overview Table 83. Boehringer Ingelheim Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Coccidiosis Vaccines Product Portfolio Table 85. Boehringer Ingelheim Recent Development Table 86. Ceva Santé Animale Company Information Table 87. Ceva Santé Animale Business Overview Table 88. Ceva Santé Animale Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ceva Santé Animale Coccidiosis Vaccines Product Portfolio Table 90. Ceva Santé Animale Recent Development Table 91. HIPRA Company Information Table 92. HIPRA Business Overview Table 93. HIPRA Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. HIPRA Coccidiosis Vaccines Product Portfolio Table 95. HIPRA Recent Development Table 96. Huvepharma Company Information Table 97. Huvepharma Business Overview Table 98. Huvepharma Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Huvepharma Coccidiosis Vaccines Product Portfolio Table 100. Huvepharma Recent Development Table 101. MSD Animal Health Company Information Table 102. MSD Animal Health Business Overview Table 103. MSD Animal Health Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. MSD Animal Health Coccidiosis Vaccines Product Portfolio Table 105. MSD Animal Health Recent Development Table 106. Nisseiken Company Information Table 107. Nisseiken Business Overview Table 108. Nisseiken Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Nisseiken Coccidiosis Vaccines Product Portfolio Table 110. Nisseiken Recent Development Table 111. Vaxxinova Company Information Table 112. Vaxxinova Business Overview Table 113. Vaxxinova Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Vaxxinova Coccidiosis Vaccines Product Portfolio Table 115. Vaxxinova Recent Development Table 116. Foshan Standard Biotech Company Information Table 117. Foshan Standard Biotech Business Overview Table 118. Foshan Standard Biotech Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Foshan Standard Biotech Coccidiosis Vaccines Product Portfolio Table 120. Foshan Standard Biotech Recent Development Table 121. Guangdong Winsun Bio-pharmaceutical Company Information Table 122. Guangdong Winsun Bio-pharmaceutical Business Overview Table 123. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product Portfolio Table 125. Guangdong Winsun Bio-pharmaceutical Recent Development Table 126. Hlinte Company Information Table 127. Hlinte Business Overview Table 128. Hlinte Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Hlinte Coccidiosis Vaccines Product Portfolio Table 130. Hlinte Recent Development Table 131. Qilu Qingda Bio-Pharmaceutical Company Information Table 132. Qilu Qingda Bio-Pharmaceutical Business Overview Table 133. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product Portfolio Table 135. Qilu Qingda Bio-Pharmaceutical Recent Development Table 136. Skystar Bio-pharm Company Information Table 137. Skystar Bio-pharm Business Overview Table 138. Skystar Bio-pharm Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Skystar Bio-pharm Coccidiosis Vaccines Product Portfolio Table 140. Skystar Bio-pharm Recent Development Table 141. North America Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units) Table 143. North America Coccidiosis Vaccines Sales Market Share by Country (2021-2026) Table 144. North America Coccidiosis Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Coccidiosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. North America Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Coccidiosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Coccidiosis Vaccines Market Share by Country (2021-2026) Table 149. North America Coccidiosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Coccidiosis Vaccines Market Share Forecast by Country (2027-2032) Table 151. Europe Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units) Table 153. Europe Coccidiosis Vaccines Sales Market Share by Country (2021-2026) Table 154. Europe Coccidiosis Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Coccidiosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Coccidiosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Coccidiosis Vaccines Market Share by Country (2021-2026) Table 159. Europe Coccidiosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Coccidiosis Vaccines Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Coccidiosis Vaccines Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Coccidiosis Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Coccidiosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Coccidiosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Coccidiosis Vaccines Market Share by Country (2021-2026) Table 169. Asia-Pacific Coccidiosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Coccidiosis Vaccines Market Share Forecast by Country (2027-2032) Table 171. Latin America Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units) Table 173. Latin America Coccidiosis Vaccines Sales Market Share by Country (2021-2026) Table 174. Latin America Coccidiosis Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Coccidiosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Coccidiosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Coccidiosis Vaccines Market Share by Country (2021-2026) Table 179. Latin America Coccidiosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Coccidiosis Vaccines Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Coccidiosis Vaccines Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Coccidiosis Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Coccidiosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Coccidiosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Coccidiosis Vaccines Market Share by Country (2021-2026) Table 189. Middle East and Africa Coccidiosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Coccidiosis Vaccines Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Coccidiosis Vaccines Distributors List Table 194. Coccidiosis Vaccines Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Coccidiosis Vaccines Image Figure 2. Global Coccidiosis Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coccidiosis Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Coccidiosis Vaccines Sales (2021-2032) & (K Units) Figure 5. Attenuated Vaccines Image Figure 6. Global Attenuated Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Non-attenuated Vaccines Image Figure 8. Global Non-attenuated Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Coccidiosis Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Coccidiosis Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Coccidiosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Coccidiosis Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Coccidiosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Coccidiosis Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Coccidiosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Coccidiosis Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Coccidiosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Coccidiosis Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Coccidiosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Coccidiosis Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Coccidiosis Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Poultry Image Figure 24. Global Poultry Sales YoY Growth (2021-2032) & (K Units) Figure 25. Rabbit Image Figure 26. Global Rabbit Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Coccidiosis Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Coccidiosis Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Coccidiosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Coccidiosis Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Coccidiosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Coccidiosis Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Coccidiosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Coccidiosis Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Coccidiosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Coccidiosis Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Coccidiosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Coccidiosis Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Coccidiosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Coccidiosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Coccidiosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Coccidiosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Coccidiosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Coccidiosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Coccidiosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Coccidiosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Coccidiosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Coccidiosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Coccidiosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Coccidiosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Coccidiosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Coccidiosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Coccidiosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Coccidiosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Coccidiosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Coccidiosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Coccidiosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Coccidiosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Coccidiosis Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Coccidiosis Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Attenuated Vaccines
  • Non-attenuated Vaccines
Applications
  • Poultry
  • Rabbit
  • Others
Companies covered
  • Biopharm
  • Bioproperties
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • HIPRA
  • Huvepharma
  • MSD Animal Health
  • Nisseiken
  • Vaxxinova
  • Foshan Standard Biotech
  • Guangdong Winsun Bio-pharmaceutical
  • Hlinte
  • Qilu Qingda Bio-Pharmaceutical
  • Skystar Bio-pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coccidiosis Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Coccidiosis Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Coccidiosis Vaccines Market by Type
  6. 1.3.1 Attenuated Vaccines
  7. 1.3.2 Non-attenuated Vaccines
  8. 1.4 Global Coccidiosis Vaccines Market Size by Type
  9. 1.4.1 Global Coccidiosis Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Coccidiosis Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Coccidiosis Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Coccidiosis Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Coccidiosis Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Coccidiosis Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Coccidiosis Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Coccidiosis Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Coccidiosis Vaccines Industry Trends
  2. 2.2 Coccidiosis Vaccines Industry Drivers
  3. 2.3 Coccidiosis Vaccines Industry Opportunities and Challenges
  4. 2.4 Coccidiosis Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Coccidiosis Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Coccidiosis Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Coccidiosis Vaccines Price (2021-2026)
  4. 3.4 Global Coccidiosis Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coccidiosis Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Coccidiosis Vaccines Company, Product Type & Application
  7. 3.7 Global Coccidiosis Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coccidiosis Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coccidiosis Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coccidiosis Vaccines Tier 1, Tier 2, and Tier 3
4 Coccidiosis Vaccines Regional Status and Outlook
  1. 4.1 Global Coccidiosis Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Coccidiosis Vaccines Historic Market Size by Region
  3. 4.2.1 Global Coccidiosis Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Coccidiosis Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Coccidiosis Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Coccidiosis Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Coccidiosis Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Coccidiosis Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Coccidiosis Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Coccidiosis Vaccines by Application
  1. 5.1 Coccidiosis Vaccines Market by Application
  2. 5.1.1 Poultry
  3. 5.1.2 Rabbit
  4. 5.1.3 Others
  5. 5.2 Global Coccidiosis Vaccines Market Size by Application
  6. 5.2.1 Global Coccidiosis Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Coccidiosis Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Coccidiosis Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Coccidiosis Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Coccidiosis Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Coccidiosis Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Coccidiosis Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Coccidiosis Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biopharm
  2. 6.1.1 Biopharm Company Information
  3. 6.1.2 Biopharm Business Overview
  4. 6.1.3 Biopharm Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biopharm Coccidiosis Vaccines Product Portfolio
  6. 6.1.5 Biopharm Recent Developments
  7. 6.2 Bioproperties
  8. 6.2.1 Bioproperties Company Information
  9. 6.2.2 Bioproperties Business Overview
  10. 6.2.3 Bioproperties Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bioproperties Coccidiosis Vaccines Product Portfolio
  12. 6.2.5 Bioproperties Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Coccidiosis Vaccines Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Ceva Santé Animale
  20. 6.4.1 Ceva Santé Animale Company Information
  21. 6.4.2 Ceva Santé Animale Business Overview
  22. 6.4.3 Ceva Santé Animale Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ceva Santé Animale Coccidiosis Vaccines Product Portfolio
  24. 6.4.5 Ceva Santé Animale Recent Developments
  25. 6.5 HIPRA
  26. 6.5.1 HIPRA Company Information
  27. 6.5.2 HIPRA Business Overview
  28. 6.5.3 HIPRA Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HIPRA Coccidiosis Vaccines Product Portfolio
  30. 6.5.5 HIPRA Recent Developments
  31. 6.6 Huvepharma
  32. 6.6.1 Huvepharma Company Information
  33. 6.6.2 Huvepharma Business Overview
  34. 6.6.3 Huvepharma Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Huvepharma Coccidiosis Vaccines Product Portfolio
  36. 6.6.5 Huvepharma Recent Developments
  37. 6.7 MSD Animal Health
  38. 6.7.1 MSD Animal Health Company Information
  39. 6.7.2 MSD Animal Health Business Overview
  40. 6.7.3 MSD Animal Health Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MSD Animal Health Coccidiosis Vaccines Product Portfolio
  42. 6.7.5 MSD Animal Health Recent Developments
  43. 6.8 Nisseiken
  44. 6.8.1 Nisseiken Company Information
  45. 6.8.2 Nisseiken Business Overview
  46. 6.8.3 Nisseiken Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Nisseiken Coccidiosis Vaccines Product Portfolio
  48. 6.8.5 Nisseiken Recent Developments
  49. 6.9 Vaxxinova
  50. 6.9.1 Vaxxinova Company Information
  51. 6.9.2 Vaxxinova Business Overview
  52. 6.9.3 Vaxxinova Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Vaxxinova Coccidiosis Vaccines Product Portfolio
  54. 6.9.5 Vaxxinova Recent Developments
  55. 6.10 Foshan Standard Biotech
  56. 6.10.1 Foshan Standard Biotech Company Information
  57. 6.10.2 Foshan Standard Biotech Business Overview
  58. 6.10.3 Foshan Standard Biotech Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Foshan Standard Biotech Coccidiosis Vaccines Product Portfolio
  60. 6.10.5 Foshan Standard Biotech Recent Developments
  61. 6.11 Guangdong Winsun Bio-pharmaceutical
  62. 6.11.1 Guangdong Winsun Bio-pharmaceutical Company Information
  63. 6.11.2 Guangdong Winsun Bio-pharmaceutical Business Overview
  64. 6.11.3 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product Portfolio
  66. 6.11.5 Guangdong Winsun Bio-pharmaceutical Recent Developments
  67. 6.12 Hlinte
  68. 6.12.1 Hlinte Company Information
  69. 6.12.2 Hlinte Business Overview
  70. 6.12.3 Hlinte Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hlinte Coccidiosis Vaccines Product Portfolio
  72. 6.12.5 Hlinte Recent Developments
  73. 6.13 Qilu Qingda Bio-Pharmaceutical
  74. 6.13.1 Qilu Qingda Bio-Pharmaceutical Company Information
  75. 6.13.2 Qilu Qingda Bio-Pharmaceutical Business Overview
  76. 6.13.3 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product Portfolio
  78. 6.13.5 Qilu Qingda Bio-Pharmaceutical Recent Developments
  79. 6.14 Skystar Bio-pharm
  80. 6.14.1 Skystar Bio-pharm Company Information
  81. 6.14.2 Skystar Bio-pharm Business Overview
  82. 6.14.3 Skystar Bio-pharm Coccidiosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Skystar Bio-pharm Coccidiosis Vaccines Product Portfolio
  84. 6.14.5 Skystar Bio-pharm Recent Developments
7 North America by Country
  1. 7.1 North America Coccidiosis Vaccines Sales by Country
  2. 7.1.1 North America Coccidiosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Coccidiosis Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Coccidiosis Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Coccidiosis Vaccines Market Size by Country
  6. 7.2.1 North America Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Coccidiosis Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Coccidiosis Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Coccidiosis Vaccines Sales by Country
  2. 8.1.1 Europe Coccidiosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Coccidiosis Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Coccidiosis Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Coccidiosis Vaccines Market Size by Country
  6. 8.2.1 Europe Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Coccidiosis Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Coccidiosis Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Coccidiosis Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Coccidiosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Coccidiosis Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Coccidiosis Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Coccidiosis Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Coccidiosis Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Coccidiosis Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Coccidiosis Vaccines Sales by Country
  2. 10.1.1 South America Coccidiosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Coccidiosis Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Coccidiosis Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Coccidiosis Vaccines Market Size by Country
  6. 10.2.1 South America Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Coccidiosis Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Coccidiosis Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Coccidiosis Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Coccidiosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Coccidiosis Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Coccidiosis Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Coccidiosis Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Coccidiosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Coccidiosis Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Coccidiosis Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Coccidiosis Vaccines Value Chain Analysis
  2. 12.1.1 Coccidiosis Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Coccidiosis Vaccines Production Mode & Process
  7. 12.2 Coccidiosis Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Coccidiosis Vaccines Distributors
  10. 12.2.3 Coccidiosis Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst